*DJ Tilray: 收购Natura Naturals增强公司供应品牌大麻产品的能力
*DJ Tilray: 收购Natura Naturals增强公司供应品牌大麻产品的能力
*DJ Tilray(R) To Acquire Natura Naturals Holdings Inc. For Up To C$70 Million Subject To Performance Milestones >TLRY
*DJ Tilray(R)將以高達7000萬加元的價格收購Natura Naturals Holdings Inc.，這取決於業績里程碑>TLRY
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)
(更多信息)道瓊斯通訊社(212-416-2800)
January 22, 2019 07:00 ET (12:00 GMT)
2019年1月22日美國東部時間07：00(格林尼治標準時間12：00)
Press Release: Tilray(R) to Acquire Natura Naturals Holdings Inc. for up to C$70 Million Subject to Performance Milestones
新聞稿：根據業績里程碑，Tilray(R)將以高達7000萬加元的價格收購Natura Naturals控股公司
Tilray(R) to Acquire Natura Naturals Holdings Inc. for up to C$70 Million Subject to Performance Milestones
Tilray(R)將根據業績里程碑以高達7000萬加元的價格收購Natura Naturals控股公司
Acquisition increases the Company's capacity to supply branded cannabis products
收購提高了該公司供應品牌大麻產品的能力
NANAIMO, British Columbia--(BUSINESS WIRE)--January 22, 2019--
不列顛哥倫比亞省納奈莫--(美國商業新聞網)--2019年1月22日--
Tilray, Inc. ("Tilray" or "the Company") (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced it has entered into a definitive agreement ("the Agreement") pursuant to which Tilray, through a wholly-owned subsidiary, will acquire all of the issued and outstanding securities of Natura Naturals Holdings Inc. ("Natura"), the parent company of a licensed cultivator of cannabis.
亞洲網加利福尼亞州聖何塞2月16日電全球大麻研究、種植、生產和分銷領域的領先企業Tilray公司(以下簡稱“Tilray”或“本公司”)(納斯達克市場代碼：TLRY)今天宣佈，該公司已達成一項最終協議(“該協議”)，根據該協議，Tilray公司將通過一家全資子公司收購一家特許大麻種植商的母公司Natura Naturals Holdings Inc.(“Natura”)的所有已發行和已發行證券。
As a result of the acquisition, if completed, Tilray will obtain Natura's 662,000 square-foot greenhouse cultivation facility, of which 155,000 square-feet are currently licensed, and all subsequent cannabis output from this facility. Natura, through a wholly-owned subsidiary located in Leamington, Ontario, is a licensed cultivator under the Cannabis Act specializing in the greenhouse cultivation of cannabis.
收購完成後，Tilray將獲得Natura的66.2萬平方英尺的温室種植設施，其中15.5萬平方英尺目前獲得許可，以及該設施隨後生產的所有大麻。Natura通過位於安大略省利明頓的一家全資子公司，是根據大麻法案獲得許可的種植者，專門從事温室大麻種植。
Under the terms of the definitive agreement and subject to certain customary adjustments, Tilray will deliver C$35 million at closing, comprised of C$15 million in cash and C$20 million in Tilray Class 2 common stock. Natura shareholders will receive their pro rata portion of the C$15 million closing cash amount, after the deduction of certain transaction expenses incurred by Natura and subject to applicable withholding taxes. Upon Natura reaching certain quarterly production milestones over the following twelve-month period, up to C$35 million of Tilray common stock may become payable resulting in a total purchase price of C$70 million if fully achieved.
根據最終協議的條款，根據某些慣例調整，Tilray將在交易完成時交付3500萬加元，其中包括1500萬加元的現金和2000萬加元的Tilray 2類普通股。在扣除Natura發生的某些交易費用並繳納適用的預扣税後，Natura的股東將獲得1500萬加元結賬現金金額中按比例分配的部分。當Natura在接下來的12個月內達到某些季度生產里程碑時，可能需要支付高達3500萬加元的Tilray普通股，如果完全實現，總收購價將達到7000萬加元。
"We're very pleased to have an agreement in place that allows us to expand our capacity to supply high-quality branded cannabis products to the Canadian market," said Brendan Kennedy, Tilray President and CEO. "Through an extensive and thorough search for the right supply partner, we're pleased to have come to a mutually-beneficial agreement with Natura."
Tilray公司總裁兼首席執行官布倫丹·肯尼迪説：“我們非常高興達成了一項協議，使我們能夠擴大向加拿大市場供應高質量品牌大麻產品的能力。”通過廣泛而徹底地尋找合適的供應夥伴，我們很高興與Natura達成了互惠互利的協議。“
Tilray currently operates three state-of-the-art facilities in Canada and one in Portugal: Tilray Canada Ltd. ("Tilray Canada"), a Nanaimo, British Columbia-based research, cultivation and processing facility which primarily serves the Canadian and global medical cannabis market; Tilray Portugal, Unipessoal, Lda. ("Tilray Portugal"), located in Cantanhede, a research, processing, cultivation, packaging and distribution facility which will primarily serve the medical cannabis market in Europe; High Park Farms Ltd. ("High Park Farms"), an Enniskillen, Ontario-based cultivation and processing facility primarily serving the adult-use market in Canada; and the newly-licensed High Park processing facility in London, Ontario, which will exclusively serve the adult-use market in Canada. Tilray and High Park also have cannabis supply agreements in place with Licensed Producers throughout Canada and most recently signed an exclusive sale, supply, distribution and marketing agreement to deliver High Park adult-use cannabis products in Québec with ROSE LifeScience. The proximity of Natura's facility to Tilray and High Park's existing Ontario operations is expected to be valuable in the long-term collaboration of cannabis research, cultivation and processing within the Company.
Tilray目前在加拿大經營着三家最先進的工廠，在葡萄牙經營着一家：Tilray Canada Ltd.(“Tilray Canada”)，這是一家總部設在不列顛哥倫比亞省納奈莫的研究、種植和加工廠，主要服務於加拿大和全球醫用大麻市場；Tilray葡萄牙、Unipessoal和LDA。該公司位於坎坦海德(“Tilray葡萄牙”)，這是一個主要服務於歐洲醫用大麻市場的研究、加工、種植、包裝和分銷設施；High Park Farm Ltd.(“High Park Farm”)，這是一家總部位於安大略省恩尼斯基倫的種植和加工設施，主要服務於加拿大的成人使用市場；以及新獲得許可的位於安大略省倫敦的High Park加工設施，該設施將專門服務於加拿大的成人使用市場。Tilray和High Park還與加拿大各地的特許生產商簽訂了大麻供應協議，最近還與Rose LifeScience簽署了一項獨家銷售、供應、分銷和營銷協議，在魁北克交付High Park成人用大麻產品。Natura的設施毗鄰Tilray和High Park現有的安大略省業務，預計將對該公司內部大麻研究、種植和加工的長期合作具有重要價值。
Prior to signing the definitive agreement, Tilray conducted extensive due diligence on Natura's cultivation facility and cannabis products. Prior to distribution, all cannabis products produced at the Natura facility will adhere to Tilray's stringent quality assurance standards. The increased supply from Natura will allow Tilray to expand its capacity to supply the Canadian market with high-quality branded cannabis products.
在簽署最終協議之前，Tilray對Natura的種植設施和大麻產品進行了廣泛的盡職調查。在分銷之前，Natura工廠生產的所有大麻產品都將遵守Tilray嚴格的質量保證標準。來自Natura的供應增加將使Tilray能夠擴大其向加拿大市場供應高質量品牌大麻產品的能力。
The transaction will be completed by plan of arrangement under the Ontario Business Corporations Act. Completion of the transaction will be subject to customary terms and conditions, including shareholder and court approval of the arrangement. It is anticipated that the closing of the transaction will be completed within the next 30 days. Tilray looks forward to sharing more information related to the company's increasing production capacity and global growth strategy, in the coming months.
交易將根據安大略省商業公司法的安排計劃完成。交易的完成將取決於慣例條款和條件，包括股東和法院對安排的批准。預計交易將在未來30天內完成。Tilray期待在未來幾個月分享更多與公司提高產能和全球增長戰略相關的信息。
Cowen provided a fairness opinion to Tilray's board of directors in connection with the transaction.
考恩就這筆交易向Tilray董事會提供了公平意見。
About Tilray(R)
關於Tilray(R)
Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in twelve countries spanning five continents.
Tilray公司是研究、種植、生產和分銷大麻和大麻素的全球先驅，目前為橫跨五大洲的12個國家和地區的數萬名患者和消費者提供服務。
About High Park(TM)
關於High Park(TM)
Based in Toronto and led by a team with deep experience in cannabis and global consumer brands, High Park was established to develop, produce, sell, and distribute a broad-based portfolio of adult-use cannabis brands and products. High Park is a wholly-owned subsidiary of Tilray, Inc., a global leader in cannabis cultivation, processing, and distribution. Tilray will continue to serve patients in Canada and around the world with a diverse range of pharmaceutical-grade medical cannabis products as High Park focuses on creating distinctive products for adult consumers.
High Park總部設在多倫多，由一個在大麻和全球消費品牌方面擁有豐富經驗的團隊領導，成立的目的是開發、生產、銷售和分銷基礎廣泛的成人用大麻品牌和產品組合。High Park是Tilray公司的全資子公司，Tilray公司是大麻種植、加工和分銷的全球領先者。Tilray將繼續為加拿大和世界各地的患者提供各種藥用級醫用大麻產品，High Park專注於為成年消費者創造獨特的產品。
About Natura Naturals Holdings Inc.
關於Natura Naturals控股公司
Based in Leamington, Ontario, Natura Naturals Inc., the wholly-owned subsidiary of Natura Naturals Holdings Inc. is a licensed cultivator of cannabis in accordance with the Cannabis Act and Cannabis Regulations. The company's cultivation facility is capable of producing plants in a 662,000 square-foot greenhouse facility, of which 155,000 is currently licensed, under optimal growing conditions. Natura grows high-quality cannabis which can be used for various medical and recreational applications. In addition, Natura has an extensive genetics library and continues to develop innovative products for the Canadian and international marketplace.
Natura Naturals Inc.總部設在安大略省利明頓，是Natura Naturals Holdings Inc.的全資子公司，根據“大麻法案”和“大麻條例”，該公司是一家獲得許可的大麻種植者。該公司的種植設施能夠在66.2萬平方英尺的温室設施中生產植物，其中15.5萬平方英尺目前獲得許可，生長條件最佳。Natura種植高質量的大麻，可用於各種醫療和娛樂用途。此外，Natura擁有廣泛的基因庫，並繼續為加拿大和國際市場開發創新產品。
Cautionary note regarding forward-looking statements:
有關前瞻性陳述的注意事項：
This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward-looking statements. Forward-looking statements in this press release may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions and include statements relating to Tilray's acquisition of Natura Naturals Holdings Inc., and the expected benefits resulting therefrom the ability of Tilray and Natura to satisfy the conditions pursuant to the arrangement and to close the transaction, or any future plans relating to High Park, Tilray or Natura , including increasing Tilray's production capacity and its global growth strategy. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment and future approvals and permits. Actual results, performance or achievement could differ materially from that expressed in, or implied by, any forward-looking statements in this press release, and, accordingly, you should not place undue reliance on any such forward-looking statements and they are not guarantees of future results. Forward-looking statements involve significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements. Please see the heading "Risk Factors" in Tilray's Quarterly Report on Form 10-Q, which was filed with the Securities and Exchange Commission and Canadian securities regulators on November 14, 2018, for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. Tilray does not undertake to update any forward-looking statements that are included herein, except in accordance with applicable securities laws.
本新聞稿包含“1995年美國私人證券訴訟改革法”所指的“前瞻性陳述”和加拿大證券法所指的“前瞻性信息”，或統稱為前瞻性陳述。本新聞稿中的前瞻性陳述可以通過使用“可能”、“將”、“可能”、“將”、“可能”、“預期”、“預期”、“相信”、“打算”、“計劃”、“預測”、“項目”、“估計”、“展望”和其他類似的表述來識別，包括與Tilray收購Natura Naturals Holdings Inc.有關的陳述。以及由此產生的預期收益，Tilray和Natura有能力根據該安排滿足條件並完成交易，或與High Park、Tilray或Natura相關的任何未來計劃，包括提高Tilray的產能及其全球增長戰略。前瞻性陳述並不是對未來業績的保證，而是基於管理層根據其經驗和對趨勢、現狀和預期發展的看法以及管理層認為在當時情況下相關和合理的其他因素對管理層作出的一系列估計和假設，包括對當前和未來市場狀況、當前和未來監管環境以及未來批准和許可的假設。實際結果、表現或成就可能與本新聞稿中任何前瞻性陳述所表達或暗示的內容大不相同，因此，您不應過度依賴任何此類前瞻性陳述，它們也不是對未來結果的保證。前瞻性陳述涉及重大風險、假設, 可能導致未來實際結果或預期事件與任何前瞻性陳述中明示或暗示的大不相同的不確定性和其他因素。請參閲Tilray於2018年11月14日提交給美國證券交易委員會(Securities And Exchange Commission)和加拿大證券監管機構的Form 10-Q季度報告中的“風險因素”標題，以瞭解可能導致實際結果與前瞻性信息大不相同的重大風險因素。除非符合適用的證券法，否則Tilray不承諾更新本文中包含的任何前瞻性陳述。
View source version on businesswire.com: https://www.businesswire.com/news/home/20190122005432/en/
在business wire.com上查看源代碼版本：https://www.businesswire.com/news/home/20190122005432/en/
CONTACT: For further information:
聯繫人：欲瞭解更多信息，請聯繫：
Media: Chrissy Roebuck, +1-833-206-8161, news@tilray.com
媒體：克里西·羅巴克(Chrissy Roebuck)電話：+1-833-206-8161電子郵件：news@tilray.com
Investors: Katie Turner, +1-646-277-1228, Katie.turner@icrinc.com
投資者：凱蒂·特納(Katie Turner)電話：+1-646-277-1228電子郵件：katie.turner@icrinc.com
(END) Dow Jones Newswires
(完)道瓊通訊社
January 22, 2019 07:00 ET (12:00 GMT)
2019年1月22日美國東部時間07：00(格林尼治標準時間12：00)
*DJ Tilray: Acquisition Increases the Company's Capacity to Supply Branded Cannabis Products >TLRY
*DJ Tilray：收購增加了公司供應品牌大麻產品的能力>TLRY
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)
(更多信息)道瓊斯通訊社(212-416-2800)
January 22, 2019 07:01 ET (12:01 GMT)
2019年1月22日東部時間07：01(格林尼治標準時間12：01)
Copyright (c) 2019 Dow Jones & Company, Inc.
版權所有(C)2019年道瓊斯公司。
譯文內容由第三人軟體翻譯。